Session Title: Subluxed IOLs and Scleral Fixation
Session Date/Time: Wednesday 09/10/2013 | 08:00-10:30
Paper Time: 09:13
Venue: E102 (First Floor)
First Author: : K.Dayawansa SRI LANKA
Co Author(s): :
Purpose:
To evaluate the surgical outcome of phacoemulcification of white mature cataract performed with Topical and Intracameral Anaesthesia with 2% lignocaine
Setting:
Eye Unit, General Hospital,
Polonnaruwa, SRILANKA
Methods:
Retrospective analysis of data on phacoemulcification of White Mature Cataract performed with Topical and Intracameral 2% Lignocaine for 3 months from December 2012. Few drops of Lignocaine drops instilled in to conjunctival sac just before the surgery and eye was cleaned with 5% Povidone Iodine. Temporal 2.2 mm incision followed by immediate injection of 2% Lignocaine mixed with Balanced salt solution in to anterior chamber. Capsule stained with trypan blue and routine phacoemulcification performed with vertical chop technique. All the surgeries were performed by single surgeon at Polonnaruwa General Hospital.
Surgical complications, outcome at day 01, post operative visual outcome at 2 weeks and patient demographic data were evaluated
Results:
53 eyes of 52 patients. 31 females.
None of the eyes needed any supplementary anaesthesia. No major surgical complications encountered. One eye had extended capsulorhexis but phacoemulcification was completed. In 4 eyes phaco was done through small capsulorrhexis due to hypermature nature of cataract and needed secondary capsule opening at the end of lens implantation. 5 eyes needed single suture with 10-0 nylon at main wound.
13 eyes had stromal oedema on day one and all were cleared at 2 weeks with frequent steroid eye drops
43 eyes (81%) had best corrected visual acuity 6/12 or better at two weeks
Conclusions:
Phacoemulcification on white mature cataract with topical anaesthesia seems to be safe option. Patient will not need painful injections and it could avoid unwanted high intracapsule pressure on the capsule following local anaesthesia
Financial Interest:
NONE
Please wait while information is loading.